Minimal residual disease is “a credible intermediate endpoint” for some patients with newly diagnosed acute myeloid leukemia, researchers report.
Dr. Nicholas J. Panetta, MD, FACS performed the first ever fully robotic lymphovenous bypass from incision to closure in the ...
In an interview with Targeted Oncology at the 2025 ASH Annual Meeting & Exposition, Mitul Gandhi, MD, medical oncologist, ...
The UC San Diego Health East Campus Behavioral Health Hub will provide much-needed mental health services for the region ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback